Seeking Alpha

PTIE
Pain Therapeutics

5/26/2012, 9:46 AM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
PTIE Market Currents more »
  • June 27, 2011 Pain Therapeutics (PTIE -24.7%) is Nasdaq's leading loser for the second straight session, adding to Friday's 40%-plus drop after the FDA rejected a new drug application for Remoxy, its extended release capsules of oxycodone developed with Pfizer (PFE +0.4%). Durect (DRRX -8.5%), whose technology was used to develop the drug, also adds to losses.
    Comment!
    [Healthcare, On the Move]
PTIE in Focus more »
PTIE Press Releases and Filings more »
PTIE Latest Transcript more »
Currently, there are no transcripts for PTIE.
PTIE Instablog posts more »
  • Pain Therapeutics sell signals
    Fri, Jun 17, 2011 • Jim Van Meerten • Comment!
  • ValuEngine Weekly, January 28, 2011
    Fri, Jan 28, 2011 • Steve Hach • Comment!
  • Drug Maker Pain Therapeutics (PTIE, $PTIE) Gets Drug Resubmission Approval, Ranks Third in ValuEngine Forecast Screen
    Thu, Jan 27, 2011 • Steve Hach • Comment!
  • (HCII, EGLE, PMFG, PTIE) Stock Report from CRWEFinance.com
    Tue, Nov 2, 2010 • Lynnai • Comment!
  • Big Gains For Pain Therapy Stocks Today: KG, PTIE, WPI, ENDP
    Thu, Oct 14, 2010 • BioPharma Investor • Comment!
Write a post on PTIE
PTIE StockTalks
PTIE vs. ETF Alternatives
Company Description
Currently, there's no company description for PTIE.